Skip to content

Cluster Headaches Reference

Overview

Cluster headache is a primary headache disorder within the trigeminal autonomic cephalalgias. Attacks cause severe or very severe pain on one side of the head, usually around or above the eye or at the temple. The pain is accompanied by same-side autonomic signs—such as tearing, eye redness, nasal congestion or drainage, eyelid swelling or drooping, facial sweating, or pupil change—or by marked restlessness and agitation.

Untreated attacks generally last fifteen minutes to three hours and may recur from once every other day to several times a day. The pattern varies by person and by bout. Attacks often occur at similar times of day, and nighttime attacks can wake a person from sleep.

The word ‘’cluster’’ refers to periods in which repeated attacks occur over days, weeks, or months. Episodic cluster headache includes remissions lasting at least three months; chronic cluster headache has attacks for at least a year without remission or with remissions shorter than three months.

Distinction from Migraine and Other Headaches

Cluster headache and migraine are distinct disorders, although one person can have both. Cluster attacks are usually shorter, more strictly one-sided, and more frequent within an active bout. Same-side tearing, nasal symptoms, and eyelid changes are common. Many people become restless or need to move during a cluster attack, while movement commonly worsens migraine and stillness may be more tolerable.

These are patterns rather than behavior tests. A person with cluster headache is not required to pace, and a person with migraine may also experience autonomic symptoms or agitation. Diagnosis depends on the full history.

Differential diagnosis includes other trigeminal autonomic cephalalgias, migraine, trigeminal neuralgia, sinus or dental disease, medication-related headache, and secondary causes involving the brain, eye, blood vessels, pituitary region, or other structures. A new or substantially changed severe headache pattern requires medical evaluation rather than assumption that it is another version of an established disorder.

Presentation and Bout Pattern

Pain often reaches high intensity quickly. People describe stabbing, boring, burning, crushing, or pressure-like pain centered around one eye or temple. Tearing, redness, nasal congestion, drainage, facial sweating, eyelid swelling, eyelid droop, or pupil narrowing occur on the painful side. Nausea and light or sound sensitivity can occur, particularly in people who also have migraine.

Some people pace, rock, press or strike the painful area, vocalize, or cannot tolerate touch or conversation. These responses reflect severe pain and agitation rather than aggression, psychiatric instability, or noncompliance. Injury prevention can be necessary without forcibly restraining the person.

During active bouts, alcohol is a reliable trigger for many people. Sleep disruption and strong odors may trigger attacks for some. Trigger avoidance outside a bout does not necessarily change the course, and not every attack has an identifiable trigger.

Diagnosis

Diagnosis is clinical and relies on the location, duration, frequency, associated signs, restlessness, bout pattern, and neurologic examination. A headache diary can document attack timing and treatment response, but it does not replace evaluation.

Magnetic-resonance or other imaging may be used when the presentation is new, atypical, or accompanied by findings that raise concern for a secondary cause. The abrupt onset and severity of cluster pain do not make every attack a stroke or aneurysm, but a first or changed pattern warrants appropriate investigation.

Acute Treatment

Cluster attacks require treatments that act within minutes. Oral pain medicines often take too long to be useful.

High-flow 100 percent oxygen delivered through a non-rebreather mask is a first-line abortive treatment. The 2023 European Academy of Neurology guideline strongly recommends a flow of at least twelve liters per minute for fifteen minutes. Individual prescriptions account for response, equipment, lung disease, safety, and access. Oxygen used for cluster headache is an evidence-based medical treatment, not a general relaxation technique.

Subcutaneous sumatriptan is another first-line abortive treatment. Intranasal triptans can also help but generally act less rapidly. Cardiovascular history, pregnancy, other medication, dose limits, and the number of daily attacks affect whether triptans are appropriate.

Access to oxygen can fail because of insurance rules, prescriber unfamiliarity, equipment availability, transportation restrictions, or workplace policies. A prescription is only useful when the person can reach functioning equipment quickly enough for an attack that peaks within minutes.

Transitional and Preventive Treatment

Preventive treatment begins early in a bout and aims to reduce attack frequency and severity. Verapamil is commonly used first and requires dose selection and cardiac monitoring. Lithium, topiramate, galcanezumab for episodic cluster headache, and other options may be used depending on the subtype, health history, response, and local approval.

Because preventives may take time to work, a short corticosteroid course or greater-occipital-nerve block can serve as transitional treatment. Long-term corticosteroid use carries substantial risks. Neuromodulation and invasive procedures are reserved for selected cases, particularly difficult chronic disease, after specialist assessment.

No single regimen works for every bout. Acute, transitional, and preventive treatment solve different parts of the problem and may be used together.

Course and Prognosis

Episodic bouts may recur seasonally or unpredictably and can be separated by long remissions. The timing, number of attacks, affected side, and response to treatment may change. Some episodic disease becomes chronic, and some chronic disease later develops longer remissions.

Pain severity and repeated sleep interruption can cause profound distress and anticipatory fear. Suicide risk associated with severe headache requires direct, nonjudgmental assessment and access to both effective headache treatment and mental-health care. The stigmatizing nickname “suicide headache” is not a diagnosis and can sensationalize patients’ suffering.

Historical Development

Seventeenth- and eighteenth-century clinicians described recurring one-sided headache with eye and nasal signs, but the disorder accumulated several names before ‘’cluster headache’’ became standard in the mid-twentieth century. Early vascular and histamine theories shaped unsuccessful or limited treatments.

Oxygen and rapidly acting triptans transformed acute care. Later treatment separated attack abortion, short-term transitional care, and prevention during the bout. Current research examines hypothalamic and circadian mechanisms, calcitonin gene-related peptide, genetics, and neuromodulation while established oxygen and triptan access remains uneven.

Associated Characters

Jacob Keller

Jacob developed a new episodic cluster-headache pattern in his mid-thirties after years of severe migraine. The first bout frightened him because the attacks came on faster, centered around one eye, made stillness difficult, and did not resemble his familiar migraine pattern. The number of attacks varied across the bout, with several possible in a day and repeated nighttime attacks disrupting sleep.

Logan Weston recognized that the timing, one-sided eye pain, tearing, nasal signs, and restlessness differed from Jacob’s migraines and helped him obtain neurologic evaluation. High-flow oxygen provided the first reliable rapid relief. Jacob and the people close to him then learned to keep oxygen reachable during active bouts and to distinguish cluster response from his migraine care.

His migraine and cluster headache could both impair teaching, performance, sleep, speech access, and recovery, but they did not become one blended diagnosis. During attacks, support centered on rapid treatment, low communication demand, space for safe movement, and presence without forced touch. Clara Keller learned the warning signs and could bring the oxygen setup, while responsibility for the equipment and treatment plan remained with Jacob and the adults in his care network.

Nelson Taveras

Nelson lived with cluster headaches and migraine alongside chronic pain from a stage-collapse injury. His experience of working through severe pain and being dismissed shaped how he recognized pain in Charlie Rivera and offered practical access without requiring Charlie to perform gratitude or disclose more than he wished.

Accessibility and Daily Life

Access needs can include oxygen at home, work, school, or rehearsal; a private but observable treatment space; storage that remains reachable; clear evacuation and fire-safety procedures; flexible attendance; permission to leave immediately at attack onset; reduced scheduling after sleep disruption; transportation that can carry prescribed equipment; and backup treatment when oxygen is unavailable.

During an attack, the person may need minimal speech, no touch, clear floor space for movement, and protection from impact without restraint. Another communication method may be necessary. Afterward, exhaustion and residual pain can continue after the most intense pain has ended.

Oxygen is not inherently sedating, but other treatment and the attack itself may affect safe driving, performance, clinical work, or equipment use. Plans should reflect the individual treatment rather than imposing a blanket restriction.

Medical-System and Community Context

Cluster headache is frequently mistaken for migraine, sinus disease, dental pain, substance-seeking behavior, or psychiatric crisis. Autonomic signs can be misread as crying, while pacing or self-protective movement can be treated as threatening behavior. Accurate recognition reduces delay and prevents coercive responses to pain.

Public language often treats all severe headaches as interchangeable. People with cluster headache may therefore have to explain why oxygen, injectable or intranasal medication, and immediate interruption of work are medically necessary. Clinicians and institutions can reduce that burden by documenting a rapid-response plan before the next bout.

Sources